Paul B. K. Kusserow - 02 Jan 2023 Form 4 Insider Report for AMEDISYS INC (AMED)

Role
Chief Executive Officer, Director
Signature
/s/ Jennifer R. Guckert, pursuant to a power of attorney
Issuer symbol
AMED
Transactions as of
02 Jan 2023
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 17:22:08 UTC
Previous filing
28 Apr 2022
Next filing
10 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMED Common Stock Award $0 +41,313 +11% $0.000000 420,658 02 Jan 2023 Direct F1
holding AMED Common Stock 83,764 02 Jan 2023 By Trust
holding AMED Common Stock 621 02 Jan 2023 Through 401(k) Plan F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer awarded the Reporting Person 41,313 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest 100% on the earlier of (i) the date Mr. Kusserow ceases to serve as Chief Executive Officer and (ii) one year after the date of grant.
F2 The information in this report is based on a plan statement dated as of September 30, 2022.